Mainz Biomed B.V.

5.09
-0.09 (-1.74%)
At close: Jan 29, 2025, 3:58 PM
5.13
0.76%
After-hours Jan 29, 2025, 07:56 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -28.66 -152 -248.24 -2.53K -3.98K
PS Ratio 841.61 7.59K 5.19K 4.54K 16.63K
PB Ratio 231.95 285.24 471.12 -817.29 -2.40K
P/FCF Ratio -31.62 -260.61 -925.8 -4.68K -11.23K
P/OCF Ratio -34.35 -272.23 -930.6 -4.78K -11.23K
OCF/S Ratio -24.5 -27.87 -5.58 -0.95 -1.48
Debt / Equity Ratio 2.28 0.23 0.41 -1.09 -1.24
Quick Ratio 0.91 4.29 645.64 0.27 0.57
Current Ratio 0.97 4.33 7.11 0.27 0.57
Asset Turnover 0.06 0.03 0.06 0.73 0.39
Interest Coverage -32.91 -90.47 -27.65 -1.21 -4.57
Return on Equity (ROE) -8.09 -1.88 -1.9 0.32 0.60
Return on Assets (ROA) -1.71 -1.31 -1.2 -1.32 -1.64
Return on Capital (ROIC) -4.32 -1.64 -1.08 11.36 -3.6
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin 56.91% 34.38% 30.77% 24.94% -21.77%
Net Profit Margin -2.94K% -4.99K% -2.09K% -179.55% -417.48%
Pretax Profit Margin -2.94K% -4.98K% -2.03K% -118.91% -340.11%
Operating Profit Margin -2.98K% -4.94K% -1.62K% -66.01% -327.62%
FCF Margin -2.66K% -2.91K% -560.67% -96.93% -148.01%
EBITDA Margin -2.79K% -4.85K% -1.95K% -52.2% -249.5%